| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 731.8 | 695.1 | 646.9 |
| Other income | 1.9 | 12.1 | 2.6 |
| Total income | 733.7 | 707.2 | 649.5 |
| Profit before exceptional items & tax | 30.1 | 25.0 | 19.8 |
| Exceptional items | -11.6 | 0.0 | 0.0 |
| Profit before tax | 18.5 | 25.0 | 19.8 |
| Net profit | 9.2 | 16.5 | 20.7 |
| Operating margin | 2.5% | 3.5% | 3.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -55.60% |
|---|---|
| Net profit, quarter on quarter | -44.20% |
| Revenue, year on year | +13.10% |
| Operating profit, year on year | +64.00% |
| Operating profit, quarter on quarter | +118.60% |
BSE results filing, NSE: HCG. Figures extracted from the filing.
Healthcare Global Enterprises Ltd: key numbers
- Share price
- ₹610.90
- Market cap
- ₹9,121 Cr
- Revenue (annual)
- ₹2,545 Cr
- Net profit (annual)
- ₹13.76 Cr
- P/E (TTM)
- 400.0×Sector 54.5×
- Promoter holding
- 64.21%+0.00% QoQ
- FII holding
- 2.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Healthcare Global Enterprises Ltd
All →Healthcare Global Enterprises Employee Stock Options
HealthCare Global granted 70,000 employee stock options at a Rs 495 exercise price under its 2026 ESOS. Options vest within one to seven years.
- Execution
- Vesting 1 to 7 years from grant; exercisable for up to 10 years from grant
Healthcare Global Enterprises Other Announcement
HealthCare Global Enterprises Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Healthcare Global Enterprises Board Meeting Date
HealthCare Global Enterprises will hold a board meeting on November 05, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.
Healthcare Global Enterprises Acquisition Worth ₹0 Cr
Healthcare Global's subsidiary, HCG Kenya, increased its stake in Advanced Molecular Imaging Limited (AMIL) to 50.10% by acquiring additional shares for approximately ₹0.003 Crore.
- Value
- ₹0.00 Cr
Healthcare Global Enterprises Other Announcement
The company clarified discrepancies in shareholding pattern filings, attributing differences to the timing of corporate actions following a rights issue and NDU disclosure variances.
Healthcare Global Enterprises Acquisition
Healthcare Global's subsidiary acquired an additional 0.10% stake in Advanced Molecular Imaging Limited for INR 0.00 Crore, making it a subsidiary of the company.